OR WAIT null SECS
March 01, 2017
Communication and taking the time to develop the process are key to successful transfer and scale up of biologics
November 01, 2016
Interactions between biologic drug products and the components of prefilled syringes can cause protein aggregation, but there are alternative materials that can help mitigate this problem.
June 07, 2016
The collaboration will provide GMP manufacturing ahead of future clinical studies.
June 01, 2016
Scale-up of complex, innovative products requires commercialization models that are sustainable.
April 01, 2016
Selecting a delivery method early on may be beneficial.
October 01, 2015
Surface plasmon resonance is helping define bispecific antibodies, the next-generation of biopharma therapeutics.
September 28, 2015
Although the Committee for Medicinal Products for Human Use (CHMP) gave Blincyto a positive opinion, full approval of the drug in the EMA will rely on additional clinical studies.
September 16, 2015
Under terms of the agreement, Amgen will license Xencor’s XmAb technology platform for five Amgen programs and one Xencor program.
September 14, 2015
Abenza acquired biopharmaceutical CDMO PacificGMP and expanded the company’s San Diego facility.
September 02, 2015
The collaborative effort will be focused on fully humanized antibodies.